fda semaglutide shortage resolved february 2025 announcement Ends: Compounded Versions Legal Battle FDA Announces End to Semaglutide

At Midi, we prescribe personalized GLP-1 prescriptions for weight loss

Higher concentrations require smaller injection volumes, which demand more precise syringe technique

A 25-trial meta-analysis found an average loss of 3.7 kg ( 8 lbs) roughly 34 % of starting body weight over 852 weeks compared with placebo (PubMed 2024)

Semaglutide, the active ingredient, mimics a natural hormone that targets areas of the brain involved in regulating appetite and food intake

It resolves fast

But since Ozempic contains the identical active ingredient and produces similar results, many doctors prescribe it off-label for weight management